| 1 | [SID17414966] | Active | IC50 | 1.13 | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489035, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | IC50 | 1.13 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489035 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103023266] | Active | AC50 | 1.27 | HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_Dose_DryPowder_Activity [AID602269, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103023266 | | CID | 5508807 | | Outcome | Active | | AC50 | 1.27 [uM] | | BioAssay | HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_Dose_DryPowder_Activity | | AID | 602269 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 3 | [SID103023266] | Active | AC50 | 1.27 | HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_Dose_DryPowder_Activity [AID602269, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103023266 | | CID | 5508807 | | Outcome | Active | | AC50 | 1.27 [uM] | | BioAssay | HSF-1 induced GFP reporter and Doxycycline induced RFP reporter Measured in Cell-Based System Using Plate Reader - 2038-03_Inhibitor_Dose_DryPowder_Activity | | AID | 602269 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 4 | [SID103023266] | Active | AC50 | 1.46 | Heat Shock Factor-1 (HSF-1) Luciferase Reporter Measured in Cell-Based System Using Plate Reader - 2038-01_Inhibitor_Dose_DryPowder_Activity [AID602268, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103023266 | | CID | 5508807 | | Outcome | Active | | AC50 | 1.46 [uM] | | BioAssay | Heat Shock Factor-1 (HSF-1) Luciferase Reporter Measured in Cell-Based System Using Plate Reader - 2038-01_Inhibitor_Dose_DryPowder_Activity | | AID | 602268 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 5 | [SID103023266] | Active | AC50 | 1.46 | Heat Shock Factor-1 (HSF-1) Luciferase Reporter Measured in Cell-Based System Using Plate Reader - 2038-01_Inhibitor_Dose_DryPowder_Activity [AID602268, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103023266 | | CID | 5508807 | | Outcome | Active | | AC50 | 1.46 [uM] | | BioAssay | Heat Shock Factor-1 (HSF-1) Luciferase Reporter Measured in Cell-Based System Using Plate Reader - 2038-01_Inhibitor_Dose_DryPowder_Activity | | AID | 602268 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 6 | [SID17414966] | Active | Potency | 2.5119 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 7 | [SID17414966] | Active | Potency | 2.5119 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 8 | [SID17414966] | Active | Potency | 3.1623 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 9 | [SID17414966] | Active | EC50 | 3.509 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 3.509 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID17414966] | Active | Potency | 3.5481 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 11 | [SID17414966] | Active | Potency | 3.5481 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 12 | [SID17414966] | Active | EC50 | 3.63 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 3.63 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID17414966] | Active | Potency | 3.6626 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 14 | [SID17414966] | Active | EC50 | 4.835 | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression [AID1914, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 4.835 [uM] | | BioAssay | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression | | AID | 1914 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 15 | [SID17414966] | Active | EC50 | 5.003 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 5.003 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17414966] | Active | Potency | 5.0119 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 17 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID17414966] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID17414966] | Active | EC50 | 5.668 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 5.668 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 24 | [SID17414966] | Active | Potency | 5.8048 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17414966] | Active | IC50 | 6.48 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | IC50 | 6.48 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID17414966] | Active | EC50 | 6.614 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) [AID2382, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 6.614 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) | | AID | 2382 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 27 | [SID17414966] | Active | EC50 | 6.614 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) [AID2382, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 6.614 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1) | | AID | 2382 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 28 | [SID17414966] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 29 | [SID17414966] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 30 | [SID17414966] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 31 | [SID17414966] | Active | EC50 | 7.482 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells [AID1988, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | EC50 | 7.482 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17414966] | Active | IC50 | 7.76 | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay [AID489041, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | IC50 | 7.76 [uM] | | BioAssay | Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay | | AID | 489041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID17414966] | Active | AC50 | 8.092 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | AC50 | 8.092 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID17414966] | Active | Potency | 9.2 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 35 | [SID17414966] | Active | Potency | 10 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 36 | [SID17414966] | Active | Potency | 10 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 37 | [SID17414966] | Active | AC50 | 10.89 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | AC50 | 10.89 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID17414966] | Active | Potency | 11.2202 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 39 | [SID17414966] | Active | Potency | 11.2202 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 40 | [SID17414966] | Active | Potency | 11.2202 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID17414966] | Active | Potency | 11.2202 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID17414966] | Active | Potency | 11.5821 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 43 | [SID17414966] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 44 | [SID17414966] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 45 | [SID17414966] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 46 | [SID17414966] | Active | Potency | 12.5893 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 47 | [SID17414966] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 48 | [SID17414966] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 49 | [SID17414966] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 50 | [SID17414966] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17414966 | | CID | 5508807 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|